loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2000_374___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    GSK

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Glaxo Wellcome London GB (1)

    filter

    01 Griseofulvin (1)

    filter

    01 United Kingdom (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Glaxo Wellcome London GB

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Griseofulvin

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2000-374 - Rev 01
    Withdrawn by Holder
    TSE
    2001-11-21
    2006-07-11
    182
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-374 - Rev 01 of Glaxo Wellcome London Gb

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-374 - Rev 01 of Glaxo Wellcome London Gb 1

    20

    Glaxo Wellcome London Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Griseofulvin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2000-374 - Rev 01

    This TSE Type CEP, issued on November 21, 2001, remains in force until July 11, 2006, ensuring its reliability within the pharmaceutical industry.

    Substance Number 182 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY